Filing Details

Accession Number:
0001144204-12-051883
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-18 17:02:54
Reporting Period:
2012-09-14
Filing Date:
2012-09-18
Accepted Time:
2012-09-18 16:02:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138776 Medgenics Inc. MDGN Biological Products, (No Disgnostic Substances) (2836) 980217544
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221680 L Clarence Dellio 555 California Street, Suite 365
San Francisco CA 94104
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-09-14 3,007 $10.74 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.67 to $10.82, inclusive. The reporting person undertakes to provide Medgenics, Inc., any security holder of Medgenics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.